Navigation Links
Hyperuricemia in Medical News

FDA approves ULORIC (febuxostat) for the chronic management of hyperuricemia in patients with gout

... 40 mg and 80 mg for the chronic management of hyperuricemia in patients with gout. This once-daily, oral ... for the more than five million patients who have hyperuricemia associated with gout. ULORIC was discovered by ... offers clinicians and their patients who have hyperuricemia associated with gout a new treatment option that ...

NBA Coach Maurice Cheeks Teams Up with the Gout & Uric Acid Education Society (GUAES) to Call a 'Time Out for Gout'

... Center in Philadelphia, Pennsylvania. "Untreated gout and prolonged hyperuricemia can lead to an accumulation of needle-like urate crystals that not only ... to reduce urate crystal accumulation and prevent the consequences of hyperuricemia and gout. It is important to work with your physician to monitor ...

AUA 2008: Uric acid stones may indicate arteriosclerotic diseases

... and urinary stone disease and concluded that arteriosclerotic diseases and hyperuricemia can be predictors of uric acid stones. 77.5 percent of all patients in ... 2 diabetes, but the proportion of uric acid stones in elderly men with hyperuricemia and arteriosclerotic disease was significantly higher. Metabolic ...

The Gout & Uric Acid Education Society (GUAES) Announces New Survey Results Highlighting Major Gaps in Public Awareness of Gout

... people with gout should not interpret a lack of symptoms as a "cure." Even when painful symptoms are not present, untreated gout and prolonged hyperuricemia can lead to permanent joint damage and deformity. Most experts agree that lowering a person's uric acid level to less than 6.0 mg/dL is helpful to ...

Review of Takeda's Febuxostat New Drug Application Continues Past PDUFA Date

... look forward to receiving a final approval date for febuxostat." Febuxostat is currently under review with FDA for once-daily, oral treatment of hyperuricemia in patients with gout. The NDA for febuxostat included data from multiple clinical trials involving more than 4,000 patients. In November 2008, ...

Pegloticase BLA Filing Accepted for Priority Review by FDA

... ABOUT PEGLOTICASE Pegloticase (formerly referred to as Puricase(R)) is a pegylated recombinant mammalian urate oxidase in development to control hyperuricemia and its clinical consequences in patients for whom conventional therapy is contraindicated or has been ineffective. The two Phase 3 pivotal trials ...

Basketball Star Details His Struggle With Gout

... Americans, and to debunk stereotypes about the so-called "disease of kings." According to GUAES, gouty arthritis results from a condition known as hyperuricemia -- the build-up of abnormally high levels of uric acid in the blood. A normal waste product that forms from the breakdown of purines found in cells ...

Risk Of Heart Attack Increased By Gout

... up of uric acid in blood. When chronic or severe hyperuricemia leads to urate crystals within joints, it results ... Blood Institute. There were 5,337 men with hyperuricemia at the beginning of the study. Over the study ... atherogenesis and thrombogenesis is needed. hyperuricemia is well known to be an independent risk factor ...
Hyperuricemia in Medical Technology

Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout

... the FDA approve febuxostat for the treatment of hyperuricemia in patients with gout. The vote was 12 to zero in ... be the first new treatment for the management of hyperuricemia associated with gout in more than 40 years. ... approval of febuxostat for the treatment of hyperuricemia in patients with gout, is a positive step in ...

Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout

... clinical efficacy study in gout patients with hyperuricemia in the first half of 2008. The Company is ... approved by the FDA for the treatment of hyperuricemia associated with gout in the past 40 years, ... 8% experienced serious adverse events (1). hyperuricemia in HIV There is a high prevalence ...

Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome

... (p=0.0012). The PUA response rate among patients with baseline hyperuricemia defined as plasma uric acid >7.5mg/dL was 90% with Elitek versus 53% ... at either high or potential risk for TLS: High risk for TLS was defined as hyperuricemia from the cancer at baseline (plasma uric acid >7.5 mg/dL), very ...

Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594

... Doses of RDEA806, A Novel Prodrug for the Potential Treatment of hyperuricemia Location: Le Palais de Congres de Paris - Level 1 (Abstract # THU0356) ... No new therapies have been approved by the FDA for the treatment of hyperuricemia associated with gout in the past 40 years. About RDEA594 RDEA594 is a ...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

... dizziness (3% vs 1%) -- AEs reported in >2% of patients taking BENICAR HCT(R) and more frequently than placebo included nausea (3% vs 0%), hyperuricemia (4% vs 2%), dizziness (9% vs 2%), and upper respiratory tract infection (7% vs 0%) Dosing and Administration No initial dosage ...

New Report by BioTrends Research Group to Highlight the Launch of ULORIC(R) (febuxostat)

... received FDA approval for Uloric (R) (generic name: febuxostat) on February 13, 2009. Uloric (R) is indicated for the chronic management of hyperuricemia associated with gout and represents the first product for gout that has been approved in over forty years. LaunchTrends(TM): Uloric (R) ...

Savient Provides Update on Pegloticase BLA

... KRYSTEXXA (pegloticase) (formerly referred to as Puricase(R)) is a pegylated recombinant mammalian urate oxidase in development to control hyperuricemia and its clinical consequences in patients for whom conventional therapy is contraindicated or has been ineffective. The two Phase 3 pivotal trials ...

New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering

... was dizziness (3% vs 1%) -- AEs reported in > 2% of patients taking BENICAR HCT and more frequently than placebo included nausea (3% vs 0%), hyperuricemia (4% vs 2%), dizziness (9% vs 2%), and upper respiratory tract infection (7% vs 0%) Dosing and Administration -- No initial dosage adjustments ...

New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)

... vs 1 percent). AEs reported in > 2 percent of patients taking BENICAR HCT and more frequently than placebo included nausea (3 percent vs 0 percent), hyperuricemia (4 percent vs 2 percent), dizziness (9 percent vs 2 percent), and upper respiratory tract infection (7 percent vs 0 percent). No initial dosage ...
Hyperuricemia in Medical Definition

Pathology

... 2 O Dehydration / Hypervolemia - K + Hypokalemia / Hyperkalemia - Cl − Hyperchloremia / Hypochloremia Purine and pyrimidine hyperuricemia - Lesch-Nyhan syndrome - Xanthinuria Porphyrin Acute intermittent , Gunther's , Cutanea tarda , Erythropoietic , ...
Hyperuricemia in Medical Dictionary

Gout

... that high blood levels of uric acid ( hyperuricemia ) may be a risk indicator for heart disease . ... caused by too much uric acid in the blood ( hyperuricemia ). hyperuricemia usually does no harm, and most people with high ...

Hyperuricemia

... Note: hyperuricemia does not inevitably lead to gout . In fact, ... disease . Acute Gouty Arthritis ... hyperuricemia occurs most often in men and in postmenopausal ... But if untreated, it can lead to: ... hyperuricemia Excessively high levels of uric acid in the ...

Uric acid

... elevated levels of uric acid in the blood ( hyperuricemia ). Uric acid is a waste product formed from ... caused by too much uric acid in the blood ( hyperuricemia ). hyperuricemia usually does no harm, and most people with high ...

Chest pain

... Too much thyroid hormone . Symptoms include weight loss , chest pain , cramps , diarrhea , and nervousness. Also called overactive thyroid. hyperuricemia ... ...

Hyperglycemia

... disease such as diabetic retinopathy ( eye disease ) or ... High blood sugar ( hyperglycemia ). Too much uric acid in the blood ( hyperuricemia ). Excess uric acid in the blood can lead to gout . Gastrointestinal problems such as upset stomach , gas, nausea , vomiting , and ...

Hyperkalemia

... . Tumor lysis syndrome results from rapid breakdown of malignant cells resulting in a number of metabolic abnormalities, most notably hyperuricemia , hyperkalemia , and hyperphosphatemia. hyperkalemia - high amounts of potassium in the blood ; can be diagnose d by blood test, or by ...

Hyperthyroid

... Too much thyroid hormone . Symptoms include weight loss , chest pain , cramps , diarrhea , and nervousness. Also called overactive thyroid. hyperuricemia ... Radioactive iodine used to treat hyperthyroid ism (overactive thyroid) or radiation treatment s for head or neck cancer s can destroy ...

Hyperthyroidism

... Too much thyroid hormone . Symptoms include weight loss , chest pain , cramps , diarrhea , and nervousness. Also called overactive thyroid. hyperuricemia ... Radioactive iodine used to treat hyperthyroidism (overactive thyroid) or radiation treatment s for head or neck cancer s can destroy the ...

Weight loss

... Too much thyroid hormone . Symptoms include weight loss , chest pain , cramps , diarrhea , and nervousness. Also called overactive thyroid. hyperuricemia ... ANOREXIA : Lack or loss of appetite that causes significant weight loss . ANOSCOPY : A visual examination of the anal canal with an ...

More>>

Hyperuricemia in Biological Technology

FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout

... 40 mg and 80 mg for the chronic management of hyperuricemia in patients with gout. This once-daily, oral ... for the more than five million patients who have hyperuricemia associated with gout. ULORIC was discovered by ... offers clinicians and their patients who have hyperuricemia associated with gout a new treatment option that ...

Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout

... normal sUA concentrations in gout patients with hyperuricemia (greater than or equal to 8.0 mg/dl). The primary ... related to rheumatology, and most frequently to hyperuricemia and gout. About Gout An estimated 3-5 million ... been approved by the FDA for the treatment of hyperuricemia associated with gout in the past 40 years. ...

FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA(TM) for Refractory Chronic Gout

... markets. Savient is currently developing one product: KRYSTEXXA(TM) (pegloticase) as a therapy for patients with treatment failure gout, to control hyperuricemia and to manage the signs and symptoms of gout. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA, formerly ...

Savient Announces New Date for FDA Arthritis Advisory Panel Review of KRYSTEXXA(TM) for Treatment Failure Gout

... 1, 2009. ABOUT KRYSTEXXA(TM) KRYSTEXXA (TM) (pegloticase) is a pegylated recombinant mammalian urate oxidase in development to control hyperuricemia and its clinical consequences in patients for whom conventional therapy is contraindicated or has been ineffective. The two Phase 3 pivotal trials ...
Other Contents
(Date:4/17/2014)... chronic inflammation in non-cancerous prostate tissue may have nearly ... those with no inflammation, according to results of a ... Kimmel Cancer Center. , The link between persistent inflammation ... high-grade prostate cancer those with a Gleason score ... the most aggressive and rapidly growing prostate cancers. , ...
(Date:4/17/2014)... vaccine brands for children may not be the most ... factors when choosing vaccines, driving the market toward what ... new study by University of Illinois researchers. , "The ... numerous factors," says Sheldon H. Jacobson, a co-author of ... of mathematics at the U. of I. "In an ...
(Date:4/17/2014)... at the University of California, San Diego School of ... who have suffered a recent major loss are more ... adults. , The study is published in this month,s ... . , Because compassionate behaviors are associated with better ... offer insights into ways to improve the outcomes of ...
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
(Date:4/17/2014)... 2014The development of stem cell therapies to cure a ... stem cell populations based on cell surface markers. Researchers ... marker that is highly expressed in a type of ... they describe in an article in BioResearch Open ... Inc., publishers. The article is available free on the ...
(Date:4/17/2014)... cartridge developed at Sandia National Laboratories and recently licensed ... and cheaper. , Bacillus anthracis , the ... all over the world and can cause serious, and ... bacteria can survive in harsh conditions for decades. In ... through skin contact, inhalation of spores or eating contaminated ...
(Date:4/17/2014)... to produce hydrogen sulfide in order to properly multiply ... from the Center for Craniofacial Molecular Biology at the ... Songtao Shi, principal investigator on the project, said the ... the flow of calcium ions. The essential ions activate ... or the creation of new bone tissue, and keeps ...
Breaking Biology News(10 mins):Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3
Other TagsOther Tags